MyFinsight
Home
Blog
About
Marketable securities
$204,431K
(73.12%↑ Y/Y)
Trade receivables,
net
$155,162K
(45.44%↑ Y/Y)
Inventory
$38,879K
(138.17%↑ Y/Y)
Prepaid expenses and
other current assets
$34,770K
(86.58%↑ Y/Y)
Cash and cash
equivalents
$34,121K
(-53.09%↓ Y/Y)
Restricted cash
$308K
(0.00%↑ Y/Y)
Total current assets
$467,671K
(40.54%↑ Y/Y)
Intangible assets, net
$13,687K
(-14.12%↓ Y/Y)
Operating lease
right-of-use asset
$4,253K
(146.12%↑ Y/Y)
Other assets
$2,054K
(244.63%↑ Y/Y)
Property, plant, and
equipment, net
$872K
(-37.45%↓ Y/Y)
Total assets
$488,537K
(38.62%↑ Y/Y)
Total liabilities and
stockholders equity
$488,537K
(38.62%↑ Y/Y)
Total liabilities
$267,958K
(25.53%↑ Y/Y)
Total stockholders
equity
$220,579K
(58.72%↑ Y/Y)
Accumulated deficit
-$1,134,370K
(2.45%↑ Y/Y)
Accumulated other
comprehensive income (loss)
-$656K
(-1774.29%↓ Y/Y)
Total current
liabilities
$160,340K
(54.27%↑ Y/Y)
Long-term debt, net
$101,950K
(-4.76%↓ Y/Y)
Operating lease
liability, long-term
$5,237K
(147.73%↑ Y/Y)
Other long-term
liabilities
$431K
(19.72%↑ Y/Y)
Additional paid-in capital
$1,355,593K
(4.13%↑ Y/Y)
Common stock, 0.0001
par value 300,000...
$12K
(0.00%↑ Y/Y)
Accrued and other
current liabilities
$146,786K
(67.08%↑ Y/Y)
Current portion of
long-term debt, net
$6,950K
(795.00%↑ Y/Y)
Accounts payable
$6,604K
(-56.21%↓ Y/Y)
Back
Back
Balance Sheet
logo-arcutis (1)-svg
Arcutis Biotherapeutics, Inc. (ARQT)
logo-arcutis (1)-svg
source: myfinsight.com
Arcutis Biotherapeutics, Inc. (ARQT)